The Veteran was granted a disability rating of 10 percent for endometriosis, status post left ovary resection, from April 4, 2017, to August 10, 2023. The claim for an increased rating beyond 10 percent starting August 10, 2023, was denied.
The deciding factor: The Veteran's endometriosis symptoms required continuous treatment and met the criteria for a 10 percent rating under Diagnostic Code 7629. However, there is no evidence of symptoms not controlled by treatment to warrant a higher rating.
- Claimed conditions
- endometriosis, status post left ovary resection, bilateral foot condition (Morton's neuroma and gout), kidney disease
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 10%
- Decision date
- January 24, 2024
- Citation
- 24003696
What this means for you
A partial grant means some issues were granted while others were denied or remanded — common in multi-issue claims. Look at which issues went which way, and how each was argued.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board remands the claim for service connection for cause of death to obtain a new medical opinion due to errors in previous examinations.
- Dismissed
The appeal for service connection for kidney disease, mass on kidney, and thyroidectomy was withdrawn by the Veteran's attorney representative.
- Dismissed
The appeals for service connection for various conditions were dismissed due to the Veteran's death.
- Dismissed
The appeal of entitlement to a higher rating for kidney disease was dismissed due to procedural defects in the filing of the Notice of Disagreement.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.